Jacobs Levy Equity Management, Inc Landos Biopharma, Inc. Transaction History

Jacobs Levy Equity Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.6 - $1.5 $95,325 - $238,312	-158,875 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.44 - $5.22 $228,780 - $829,327	158,875 New	158,875 $234,000
Q4 2021 Feb 14, 2022	SELL	$4.7 - $15.0 $85,417 - $272,610	-18,174 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.77 - $15.77 $177,559 - $286,603	18,174 New	18,174 $265,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.